Novel Test Helps ID Patients at High Risk of Esophageal Cancers

Novel Test Helps ID Patients at High Risk of Esophageal Cancers

A novel test developed by Johns Hopkins Kimmel Cancer Center investigators could give gastroenterologists insight into which patients with Barrett’s esophagus — a premalignant condition in which parts of the esophagus become damaged by chronic acid reflux — are likely to progress to esophageal cancer or an abnormal collection of cells called high-grade dysplasia. This information could help physicians determine how to monitor or manage patients during clinical care.

LEARN MORE